Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

MEI Pharma, Inc. - Common Stock (NQ:MEIP)

3.070 UNCHANGED
Last Price Updated: 4:00 PM EDT, Sep 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about MEI Pharma, Inc. - Common Stock

< Previous 1 2 3 4 Next >
News headline image
MEI Pharma to Report 2023 Fiscal Year End Financial Results and Provide Corporate Overview on September 26, 2023
From MEI Pharma, Inc.
Via Business Wire
News headline image
MEI Pharma Confirms Receipt of Director Nominations From Anson and Cable Car
From MEI Pharma, Inc.
Via Business Wire
News headline image
MEI Pharma Announces First Patient Dosed in Clinical Study Evaluating ME-344 Plus Bevacizumab (AVASTIN®) in Patients with Previously Treated Metastatic Colorectal Cancer
From MEI Pharma, Inc.
Via Business Wire
News headline image
MEI Pharma Announces Results of Special Meeting of Stockholders
From MEI Pharma, Inc.
Via Business Wire
News headline image
MEI Pharma Reminds Shareholders to Vote Today FOR the Infinity Transaction
From MEI Pharma, Inc.
Via Business Wire
News headline image
MEI Pharma Responds to Anson and Cable Car
From MEI Pharma, Inc.
Via Business Wire
News headline image
Anson and Cable Car File Preliminary Consent Materials to Remove Entire Board of Directors at MEI Pharma, Inc.
From Anson Funds Management LP
Via GlobeNewswire
News headline image
MEI Pharma Encourages Shareholders to Vote FOR the Infinity Transaction
From MEI Pharma, Inc.
Via Business Wire
News headline image
MEI Pharma Postpones Special Meeting of Shareholders
From MEI Pharma, Inc.
Via Business Wire
News headline image
MEI Pharma Provides Final Reminder to Shareholders to Vote Today FOR the Merger With Infinity Pharmaceuticals
From MEI Pharma, Inc.
Via Business Wire
News headline image
MEI Pharma Reminds Shareholders to Vote FOR the Merger with Infinity Pharmaceuticals
From MEI Pharma, Inc.
Via Business Wire
News headline image
MEI Pharma Highlights Recommendation by Leading Independent Proxy Advisory Firm ISS to Vote “FOR” Pending Transaction with Infinity Pharmaceuticals
From MEI Pharma, Inc.
Via Business Wire
News headline image
MEI Pharma Mails Letter to Shareholders Reiterating Value Creating Potential of Proposed Transaction with Infinity Pharmaceuticals
From MEI Pharma, Inc.
Via Business Wire
News headline image
MEI Pharma Responds to Anson and Cable Car
From MEI Pharma, Inc.
Via Business Wire
News headline image
Anson Funds and Cable Car Capital Issue Statement Regarding the Inferior Proposed Transaction between MEI Pharma and Infinity Pharmaceuticals
From Anson Funds Management LP
Via GlobeNewswire
News headline image
MEI Pharma and Infinity Pharmaceuticals Host Video Webcast Providing Overview and Update on Pending Merger to Advance Three Promising Clinical Oncology Candidates
From Infinity Pharmaceuticals, Inc.
Via Business Wire
News headline image
MEI Pharma Announces Planned Departure of Chief Financial Officer Brian Drazba and Appointment of Justin File as Successor
From MEI Pharma, Inc.
Via Business Wire
News headline image
MEI Pharma Announces Planned Departure of CEO Daniel P. Gold, Ph.D. and Appointment of David M. Urso as Successor
From MEI Pharma, Inc.
Via Business Wire
News headline image
Anson Funds and Cable Car Capital Issue Statement Regarding MEI Pharma’s Rejection of Their Acquisition Proposal
From Anson Funds Management LP
Via GlobeNewswire
News headline image
MEI Pharma Board of Directors Rejects Unsolicited Proposal
From MEI Pharma, Inc.
Via Business Wire
News headline image
MEI Pharma Confirms Receipt of Unsolicited Acquisition Proposal
From MEI Pharma, Inc.
Via Business Wire
News headline image
MEI Pharma Announces Update of Ongoing Phase 1 Study Evaluating Oral CDK9 Inhibitor Voruciclib Alone and in Combination with Venetoclax in Patients with Acute Myeloid Leukemia or B-Cell Malignancies
From MEI Pharma, Inc.
Via Business Wire
News headline image
MEI Pharma Reports Third Quarter Fiscal Year 2023 Results and Operational Highlights
From MEI Pharma, Inc.
Via Business Wire
News headline image
MEI Pharma Announces 1-for-20 Reverse Stock Split
From MEI Pharma, Inc.
Via Business Wire
News headline image
MEIP STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Merger of MEI Pharma, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
News headline image
MEI Pharma and Infinity Pharmaceuticals Announce Definitive Merger Agreement to Advance Three Promising Clinical Oncology Candidates
From MEI Pharma, Inc.
Via Business Wire
News headline image
MEI Pharma Reports Second Quarter Fiscal Year 2023 Results and Operational Highlights
From MEI Pharma, Inc.
Via Business Wire
News headline image
MEI Pharma Announces Adjournment of Annual Meeting of Stockholders
From MEI Pharma, Inc.
Via Business Wire
News headline image
MEI Pharma Initiates Strategic Realignment
From MEI Pharma, Inc.
Via Business Wire
News headline image
MEI Pharma and Kyowa Kirin Announce Discontinuation of Zandelisib Development Outside of Japan Following Recent FDA Meeting
From MEI Pharma, Inc.
Via Business Wire
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.